Francesco Barchiesi

ORCID: 0000-0003-1098-902X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Nail Diseases and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Antimicrobial Peptides and Activities
  • Plant Pathogens and Fungal Diseases
  • Antibiotic Use and Resistance
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Fungal Biology and Applications
  • Long-Term Effects of COVID-19
  • Mycotoxins in Agriculture and Food
  • Infectious Diseases and Mycology
  • HIV/AIDS oral health manifestations
  • Coccidia and coccidiosis research
  • Parasitic Infections and Diagnostics
  • Nematode management and characterization studies
  • Bacterial Identification and Susceptibility Testing
  • Biochemical and Structural Characterization
  • HIV/AIDS drug development and treatment
  • Antimicrobial Resistance in Staphylococcus
  • Neutropenia and Cancer Infections
  • HIV-related health complications and treatments
  • Nosocomial Infections in ICU
  • Entomopathogenic Microorganisms in Pest Control

Marche Polytechnic University
2016-2025

San Salvatore Hospital
2025

Azienda Socio Sanitaria Territoriale Lariana
2023-2025

Ospedali Riuniti Umberto I
1998-2023

Ospedali Riuniti Marche Nord
2019-2023

University of Bologna
2023

National Tsunami Warning Center
2021

Statens Serum Institut
2020

Azienda Ospedaliero Universitaria Ospedali Riuniti
2016-2020

San Gallicano Hospital
2018

This study included 676 surgery patients with signs and symptoms indicative of wound infections, who presented over the course 6 years. Bacterial pathogens were isolated from 614 individuals. A single etiologic agent was identified in 271 patients, multiple agents found 343, no 62. high preponderance aerobic bacteria observed. Among common Staphylococcus aureus (191 28.2%), Pseudomonas aeruginosa (170 25.2%), Escherichia coli (53 7.8%), epidermidis (48 7.1%), Enterococcus faecalis (38 5.6%).

10.1128/jcm.38.2.918-922.2000 article EN Journal of Clinical Microbiology 2000-02-01
Michele Bartoletti Maddalena Giannella Luigia Scudeller Sara Tedeschi Matteo Rinaldi and 88 more Linda Bussini Giacomo Fornaro Renato Pascale Livia Pancaldi Zeno Pasquini Filippo Trapani Lorenzo Badia Caterina Campoli Marina Tadolini Luciano Attard Massimo Puoti Marco Merli Cristina Mussini Marianna Menozzi Marianna Meschiari Mauro Codeluppi Francesco Barchiesi Francesco Cristini Annalisa Saracino Alberto Licci Silvia Rapuano Tommaso Tonetti Paolo Gaibani V. Marco Ranieri Pierluigi Viale Luigi Raumer Luca Guerra Fabio Tumietto Alessandra Cascavilla Eleonora Zamparini Gabriella Verucchi Simona Coladonato Arianna Rubin Stefano Ianniruberto Eugenia Francalanci Francesca Volpato Giulio Virgili Nicolò Rossi Elena Rosselli Del Turco Viola Guardigni Giovanni Fasulo Nicola Dentale Ciro Fulgaro Giorgio Legnani Emanuele Campaci Cristina Basso Alberto Zuppiroli Amalia Sanna Passino Giulia Tesini Lucia Angelelli Adriana Badeanu Agostino Rossi Giulia Santangelo Flovia Dauti Vidak Koprivika Nicholas Roncagli Ioannis Tzimas Guido Maria Liuzzi Irid Baxhaku Letizia Pasinelli Mattia Neri Tommaso Zanaboni Francesco Dell’Omo Oana Vatamanu Gregorio Tugnoli Idina Zavatta Stefano Antonini Chiara Pironi Elena Piccini Luca Esposito Alessandro Zuccotti Giacomo Urbinati Agnese Pratelli A Sarti Michela Semprini Enrico Evangelisti Mara D’Onofrio Giuseppe Sasdelli Giacinto Pizzilli Elisabetta Pierucci Giada Rossini Caterina Vocale Lorenzo Marconi Maria Cristina Leoni Elisa Fronti Giovanni Guaraldi Davide Fiore Bavaro Paola Laghetti

10.1016/j.cmi.2020.08.003 article EN publisher-specific-oa Clinical Microbiology and Infection 2020-08-08

Abstract Objectives To analyse the impact of cefiderocol use on outcome in patients admitted to ICU for severe COVID-19 and further diagnosed with carbapenem-resistant Acinetobacter baumannii (CR-Ab) infection. Methods Retrospective multicentre observational study was performed at four Italian hospitals, from January 2020 April 2021. Adult CR-Ab infections were enrolled. Patients treated cefiderocol, as compassionate use, least 72 h compared those receiving alternative regimens. Primary...

10.1093/jacamr/dlab174 article EN cc-by-nc JAC-Antimicrobial Resistance 2021-09-30
Francesco Menichetti Patrizia Popoli Maria Puopolo Stefania Spila Alegiani Giusy Tiseo and 95 more Alessandro Bartoloni Giuseppe Vittorio De Socio Sauro Luchi Pierluigi Blanc Massimo Puoti Elena Toschi Marco Massari Lucia Palmisano Giuseppe Marano Margherita Chiamenti Laura Martinelli Silvia Franchi Carlo Pallotto L Suardi Barbara Luciani Pasqua Marco Merli Plinio Fabiani Luca Bertolucci Beatrice Borchi Sara Modica Sara Moneta Giulia Marchetti Antonella d’Arminio Monforte Laura Stoppini Nadia Ferracchiato Stefania Piconi Claudio Fabbri Enrico Beccastrini Riccardo Saccardi Andrea Giacometti Sara Esperti Piera Pierotti Laura Bernini Cláudia Bianco Sara Benedetti Alessandra Lanzi Paolo Bonfanti Marco Massari Spartaco Sani Annalisa Saracino Antonella Castagna Luigia Trabace Maria Lanza Daniele Focosi Alessandro Mazzoni Mauro Pistello Marco Falcone Roberto Palazzolo Salvatore Casari Alessandro Occhionero Tiziana Grazzini Dina Leonarda Silvestri Mariacarla Iorio Andrea Tosti Daniela Francisci Cecilia Becattini Matteo Pirro Mauro Marchesi Sabrina Bastianelli Sara Pierucci Chiara Busti Antonella Mencacci Silvia Bozza Barbara Camilloni Valentina Annoni Chiara Bellotto A Cioppi Giorgia Querci Giacomo Ciusa Michela Tassara Anna Danise Silvia Chigiotti Giovanna Morelli Micaela Meini Valentina Galfo Simone Ferranti Enrico Tagliaferri Riccardo Iapoce Chiara Barbieri Arianna Forniti Claudio Caroselli Stefano Verdenelli Fabio Monzani Paola Mazzetti Giovanna Moscato Francesco Barchiesi Mauro Andreotti Fausto Baldanti Andrea Binelli Maria Rosaria Capobianchi Roberto Da Daniela Di Sevo Paola Fazi Cinzia Gasparrini Ilaria Ippoliti

<h3>Importance</h3> Convalescent plasma (CP) has been generally unsuccessful in preventing worsening of respiratory failure or death hospitalized patients with COVID-19 pneumonia. <h3>Objective</h3> To evaluate the efficacy CP plus standard therapy (ST) vs ST alone <h3>Design, Setting, and Participants</h3> This prospective, open-label, randomized clinical trial enrolled (1:1 ratio) pneumonia to receive between July 15 December 8, 2020, at 27 sites Italy. Hospitalized adults a partial...

10.1001/jamanetworkopen.2021.36246 article EN cc-by-nc-nd JAMA Network Open 2021-11-29

Abstract Dengue is the most common arboviral disease globally. It caused by four distinct but closely related viruses (DENV-1, -2, -3, and − 4) transmitted through bites of infected Aedes species mosquito vectors. In last 50 years, incidence has increased 30-fold with increasing geographic expansion to new countries. Here we report important autochthonous epidemic in Italy ever recorded a total 86 confirmed cases occurring September 2024 Fano. They were DENV-2. 61 fever, 21 warning signs no...

10.1007/s15010-025-02476-1 article EN cc-by Infection 2025-01-30

The use of Etest strips for antimicrobial susceptibility testing is a new and promising method with broad applications in microbiology. Since these contain predefined continuous gradient drug, it possible to obtain reproducible, quantitative MIC reading. We performed prospective double-blinded study compare the National Committee Clinical Laboratory Standards (Villanova, Pa.) broth macrodilution methods determining MICs fluconazole, itraconazole, ketoconazole 100 clinical isolates (25...

10.1128/jcm.33.3.535-540.1995 article EN Journal of Clinical Microbiology 1995-03-01

A comparative study of broth macro- and microdilution methods for susceptibility testing fluconazole, itraconazole, flucytosine, amphotericin B was conducted with 273 yeasts. The clinical isolates included 100 Candida albicans, 28 tropicalis, 25 parapsilosis, 15 lusitaniae, krusei, 50 Cryptococcus neoformans var. neoformans, Torulopsis (Candida) glabrata, Trichosporon beigelii strains. Both were performed according to the National Committee Clinical Laboratory Standards' (NCCLS)...

10.1128/jcm.32.10.2494-2500.1994 article EN Journal of Clinical Microbiology 1994-10-01

ABSTRACT Candida tropicalis is less commonly isolated from clinical specimens than albicans . Unlike C. , which can be occasionally found as a commensal, almost always associated with the development of fungal infections. In addition, has been reported to resistant fluconazole (FLC). To analyze FLC resistance in an FLC-susceptible strain (ATCC 750) (MIC = 1.0 μg/ml) was cultured liquid medium containing increasing concentrations 8.0 128 μg/ml. The developed variable degrees paralleled used...

10.1128/aac.44.6.1578-1584.2000 article EN Antimicrobial Agents and Chemotherapy 2000-06-01

ABSTRACT The aim of this study was to compare MICs fluconazole, itraconazole, posaconazole, and voriconazole obtained by the European Committee on Antibiotic Susceptibility Testing (EUCAST) CLSI (formerly NCCLS) methods in each six centers for 15 Candida albicans (5 fluconazole-resistant 4 susceptible-dose-dependent [S-DD] isolates), 10 C. dubliniensis , 7 glabrata (2 5 guilliermondii krusei 9 lusitaniae parapsilosis tropicalis (1 isolate) isolates. were visually at 24 48 h...

10.1128/jcm.43.8.3884-3889.2005 article EN Journal of Clinical Microbiology 2005-08-01

Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported the literature from 1985 to 2013. IA was diagnosed after a median of 25 days transplantation and involved single organ 51% cases, whereas remaining multiple sites were involved. The most common infecting Aspergillus species fumigatus (73%), flavus (14%), terreus (8%). Amphotericin B drug frequently used, it followed by voriconazole itraconazole. Combination...

10.1002/lt.24032 article EN Liver Transplantation 2014-10-28

Background Candidemia is a life-threatening fungal infection and it can affect patients of all ages. Characterization candidemia in the elderly lacking. Methods We performed retrospective study adults (≥ 18 years) with diagnosed our center 2010–2015. Demographics, comorbidities, clinical microbiologic characteristics, antifungal treatment outcome were compared between older (≤65 younger (>65 patients. Results Among 302 identified during period, 188 (62%) belonged to group. Comorbidities...

10.1371/journal.pone.0176576 article EN cc-by PLoS ONE 2017-05-11

Remdesivir is a prodrug with in vitro activity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Its clinical efficacy patients COVID-19 under mechanical ventilation remains to be evaluated.This study includes confirmed SARS-CoV-2 infection admitted the ICU of Pesaro hospital between 29 February and 20 March 2020. During this period, remdesivir was provided on compassionate use basis. Clinical characteristics outcome treated were collected retrospectively compared those...

10.1093/jac/dkaa321 article EN other-oa Journal of Antimicrobial Chemotherapy 2020-07-08

Abstract Objectives Terbinafine resistance is increasingly reported in Trichophyton, rendering susceptibility testing particularly important non-responding cases. We performed a multicentre evaluation of six EUCAST-based methods. Methods Ten laboratories tested terbinafine, itraconazole, voriconazole and amorolfine against blinded panel 38 terbinafine WT target gene mutant isolates. E.Def 9.3.1 modifications included: medium with/without addition chloramphenicol cycloheximide (CC),...

10.1093/jac/dkaa111 article EN Journal of Antimicrobial Chemotherapy 2020-03-06
Coming Soon ...